-
-
Call more information
660-596-2224 -
Associated Press A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks. Switzerland-based Roche reported the results for tocilizumab, sold now as Actemra and RoActemra for treating rheumatoid […]
Read MoreAuthors: Byron Erath et al Discover How smoke moves inside a bar or outside in fresh air can help in visualizing how the coronavirus spreads. When people envision social distancing, they typically think about the “6-foot rule.” It’s true that staying 6 feet from other people can reduce the chance of a coronavirus-laden respiratory droplet […]
Read MoreAuthors: William G. Tharp, M.D., Ph.D. et al Anesthesiology Volume 133 Issue 4 Oct 2020 Background Body habitus, pneumoperitoneum, and Trendelenburg positioning may each independently impair lung mechanics during robotic laparoscopic surgery. This study hypothesized that increasing body mass index is associated with more mechanical strain and alveolar collapse, and these impairments are exacerbated by […]
Read Moreby Johns Hopkins University School of Medicine Johns Hopkins Medicine pain experts have joined the International Association for the Study of Pain (IASP) and collaborators worldwide to make a subtle but important update to the definition of “pain” for the first time in 40 years. With this change, the experts aim to make pain diagnosis and […]
Read MoreA panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths. The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has […]
Read More